 | • レポートコード：MRC2-11QY11328 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は脳血管障害のグローバル市場について調査・分析したレポートです。種類別（頸動脈内膜剥離術、頸動脈血管形成術/頸動脈ステント留置術、薬物療法（アスピリン・チクロピジン・スルフィンピラゾン））市場規模、用途別（学術・研究機関、製薬・バイオ技術企業、病院・診断センター、委託研究機関、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別脳血管障害の競争状況、市場シェア ・世界の脳血管障害市場：種類別市場規模 2015年-2020年（頸動脈内膜剥離術、頸動脈血管形成術/頸動脈ステント留置術、薬物療法（アスピリン・チクロピジン・スルフィンピラゾン）） ・世界の脳血管障害市場：種類別市場規模予測 2021年-2026年（頸動脈内膜剥離術、頸動脈血管形成術/頸動脈ステント留置術、薬物療法（アスピリン・チクロピジン・スルフィンピラゾン）） ・世界の脳血管障害市場：用途別市場規模 2015年-2020年（学術・研究機関、製薬・バイオ技術企業、病院・診断センター、委託研究機関、その他） ・世界の脳血管障害市場：用途別市場規模予測 2021年-2026年（学術・研究機関、製薬・バイオ技術企業、病院・診断センター、委託研究機関、その他） ・北米の脳血管障害市場分析：米国、カナダ ・ヨーロッパの脳血管障害市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの脳血管障害市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の脳血管障害市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの脳血管障害市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Johnson & Johnson、Amgen、GlaxoSmithKline、Sanofi-Aventis、Merck、Sangamo BioSciences、Aldagen ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Cerebrovascular diseases are a group of condition characterized by a certain dysfunction of blood vessels supplying the brain and also affect the flow of blood in an individual’s brain. For proper functioning of the brain, it needs certain nutrients and oxygen from the arteries. However, if there is any kind of restriction in the blood flow, the brain cells begin to die. The prime causes of cerebrovascular disease are cerebral thrombosis, cerebral embolism, and cerebral hemorrhage. Due to cerebrovascular disease, part of the brain is affected due to bleeding and thereby leads to different types of cerebrovascular diseases such as stroke, transient ischaemic attack (TIA), vascular dementia, and subarachnoid hemorrhage.
According to Centers for Disease Control and Prevention, cerebrovascular disease is the fourth most common cause of death in the U.S. Following North America, European countries are also expected to show steady growth in the market. In the next few years, Asia-Pacific would show remarkable growth in the cerebrovascular disease market as it is developing at a very rapid pace. The factors which would fuel the growth of the market in Asia Pacific are increasing awareness about cerebrovascular disease, certain family history related to the disease and rapidly developing technologically advanced treatments.
Market Analysis and Insights: Global Cerebrovascular Disease Market
The global Cerebrovascular Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Cerebrovascular Disease Scope and Market Size
Cerebrovascular Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cerebrovascular Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Johnson & Johnson
Amgen
GlaxoSmithKline
Sanofi-Aventis
Merck
Sangamo BioSciences
Aldagen
…
Market segment by Type, the product can be split into
Carotid Endarterectomy
Carotid Angioplasty Or Carotid Artery Stenting
Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
Market segment by Application, split into
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Contract Research Organizations
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cerebrovascular Disease Revenue
1.4 Market by Type
1.4.1 Global Cerebrovascular Disease Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Carotid Endarterectomy
1.4.3 Carotid Angioplasty Or Carotid Artery Stenting
1.4.4 Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
1.5 Market by Application
1.5.1 Global Cerebrovascular Disease Market Share by Application: 2020 VS 2026
1.5.2 Academic & Research Institutes
1.5.3 Pharmaceutical & Biotechnology Companies
1.5.4 Hospitals & Diagnostic Centers
1.5.5 Contract Research Organizations
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Cerebrovascular Disease Market Perspective (2015-2026)
2.2 Global Cerebrovascular Disease Growth Trends by Regions
2.2.1 Cerebrovascular Disease Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cerebrovascular Disease Historic Market Share by Regions (2015-2020)
2.2.3 Cerebrovascular Disease Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cerebrovascular Disease Market Growth Strategy
2.3.6 Primary Interviews with Key Cerebrovascular Disease Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cerebrovascular Disease Players by Market Size
3.1.1 Global Top Cerebrovascular Disease Players by Revenue (2015-2020)
3.1.2 Global Cerebrovascular Disease Revenue Market Share by Players (2015-2020)
3.1.3 Global Cerebrovascular Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cerebrovascular Disease Market Concentration Ratio
3.2.1 Global Cerebrovascular Disease Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cerebrovascular Disease Revenue in 2019
3.3 Cerebrovascular Disease Key Players Head office and Area Served
3.4 Key Players Cerebrovascular Disease Product Solution and Service
3.5 Date of Enter into Cerebrovascular Disease Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cerebrovascular Disease Historic Market Size by Type (2015-2020)
4.2 Global Cerebrovascular Disease Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Cerebrovascular Disease Market Size by Application (2015-2020)
5.2 Global Cerebrovascular Disease Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cerebrovascular Disease Market Size (2015-2020)
6.2 Cerebrovascular Disease Key Players in North America (2019-2020)
6.3 North America Cerebrovascular Disease Market Size by Type (2015-2020)
6.4 North America Cerebrovascular Disease Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cerebrovascular Disease Market Size (2015-2020)
7.2 Cerebrovascular Disease Key Players in Europe (2019-2020)
7.3 Europe Cerebrovascular Disease Market Size by Type (2015-2020)
7.4 Europe Cerebrovascular Disease Market Size by Application (2015-2020)
8 China
8.1 China Cerebrovascular Disease Market Size (2015-2020)
8.2 Cerebrovascular Disease Key Players in China (2019-2020)
8.3 China Cerebrovascular Disease Market Size by Type (2015-2020)
8.4 China Cerebrovascular Disease Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cerebrovascular Disease Market Size (2015-2020)
9.2 Cerebrovascular Disease Key Players in Japan (2019-2020)
9.3 Japan Cerebrovascular Disease Market Size by Type (2015-2020)
9.4 Japan Cerebrovascular Disease Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cerebrovascular Disease Market Size (2015-2020)
10.2 Cerebrovascular Disease Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cerebrovascular Disease Market Size by Type (2015-2020)
10.4 Southeast Asia Cerebrovascular Disease Market Size by Application (2015-2020)
11 India
11.1 India Cerebrovascular Disease Market Size (2015-2020)
11.2 Cerebrovascular Disease Key Players in India (2019-2020)
11.3 India Cerebrovascular Disease Market Size by Type (2015-2020)
11.4 India Cerebrovascular Disease Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cerebrovascular Disease Market Size (2015-2020)
12.2 Cerebrovascular Disease Key Players in Central & South America (2019-2020)
12.3 Central & South America Cerebrovascular Disease Market Size by Type (2015-2020)
12.4 Central & South America Cerebrovascular Disease Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Details
13.1.2 Johnson & Johnson Business Overview
13.1.3 Johnson & Johnson Cerebrovascular Disease Introduction
13.1.4 Johnson & Johnson Revenue in Cerebrovascular Disease Business (2015-2020))
13.1.5 Johnson & Johnson Recent Development
13.2 Amgen
13.2.1 Amgen Company Details
13.2.2 Amgen Business Overview
13.2.3 Amgen Cerebrovascular Disease Introduction
13.2.4 Amgen Revenue in Cerebrovascular Disease Business (2015-2020)
13.2.5 Amgen Recent Development
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Details
13.3.2 GlaxoSmithKline Business Overview
13.3.3 GlaxoSmithKline Cerebrovascular Disease Introduction
13.3.4 GlaxoSmithKline Revenue in Cerebrovascular Disease Business (2015-2020)
13.3.5 GlaxoSmithKline Recent Development
13.4 Sanofi-Aventis
13.4.1 Sanofi-Aventis Company Details
13.4.2 Sanofi-Aventis Business Overview
13.4.3 Sanofi-Aventis Cerebrovascular Disease Introduction
13.4.4 Sanofi-Aventis Revenue in Cerebrovascular Disease Business (2015-2020)
13.4.5 Sanofi-Aventis Recent Development
13.5 Merck
13.5.1 Merck Company Details
13.5.2 Merck Business Overview
13.5.3 Merck Cerebrovascular Disease Introduction
13.5.4 Merck Revenue in Cerebrovascular Disease Business (2015-2020)
13.5.5 Merck Recent Development
13.6 Sangamo BioSciences
13.6.1 Sangamo BioSciences Company Details
13.6.2 Sangamo BioSciences Business Overview
13.6.3 Sangamo BioSciences Cerebrovascular Disease Introduction
13.6.4 Sangamo BioSciences Revenue in Cerebrovascular Disease Business (2015-2020)
13.6.5 Sangamo BioSciences Recent Development
13.7 Aldagen
13.7.1 Aldagen Company Details
13.7.2 Aldagen Business Overview
13.7.3 Aldagen Cerebrovascular Disease Introduction
13.7.4 Aldagen Revenue in Cerebrovascular Disease Business (2015-2020)
13.7.5 Aldagen Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Cerebrovascular Disease Key Market Segments
Table 2. Key Players Covered: Ranking by Cerebrovascular Disease Revenue
Table 3. Ranking of Global Top Cerebrovascular Disease Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cerebrovascular Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Carotid Endarterectomy
Table 6. Key Players of Carotid Angioplasty Or Carotid Artery Stenting
Table 7. Key Players of Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
Table 8. Global Cerebrovascular Disease Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Cerebrovascular Disease Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Cerebrovascular Disease Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Cerebrovascular Disease Market Share by Regions (2015-2020)
Table 12. Global Cerebrovascular Disease Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Cerebrovascular Disease Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Cerebrovascular Disease Market Growth Strategy
Table 18. Main Points Interviewed from Key Cerebrovascular Disease Players
Table 19. Global Cerebrovascular Disease Revenue by Players (2015-2020) (Million US$)
Table 20. Global Cerebrovascular Disease Market Share by Players (2015-2020)
Table 21. Global Top Cerebrovascular Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cerebrovascular Disease as of 2019)
Table 22. Global Cerebrovascular Disease by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cerebrovascular Disease Product Solution and Service
Table 25. Date of Enter into Cerebrovascular Disease Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cerebrovascular Disease Market Size by Type (2015-2020) (Million US$)
Table 28. Global Cerebrovascular Disease Market Size Share by Type (2015-2020)
Table 29. Global Cerebrovascular Disease Revenue Market Share by Type (2021-2026)
Table 30. Global Cerebrovascular Disease Market Size Share by Application (2015-2020)
Table 31. Global Cerebrovascular Disease Market Size by Application (2015-2020) (Million US$)
Table 32. Global Cerebrovascular Disease Market Size Share by Application (2021-2026)
Table 33. North America Key Players Cerebrovascular Disease Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Cerebrovascular Disease Market Share (2019-2020)
Table 35. North America Cerebrovascular Disease Market Size by Type (2015-2020) (Million US$)
Table 36. North America Cerebrovascular Disease Market Share by Type (2015-2020)
Table 37. North America Cerebrovascular Disease Market Size by Application (2015-2020) (Million US$)
Table 38. North America Cerebrovascular Disease Market Share by Application (2015-2020)
Table 39. Europe Key Players Cerebrovascular Disease Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Cerebrovascular Disease Market Share (2019-2020)
Table 41. Europe Cerebrovascular Disease Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Cerebrovascular Disease Market Share by Type (2015-2020)
Table 43. Europe Cerebrovascular Disease Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Cerebrovascular Disease Market Share by Application (2015-2020)
Table 45. China Key Players Cerebrovascular Disease Revenue (2019-2020) (Million US$)
Table 46. China Key Players Cerebrovascular Disease Market Share (2019-2020)
Table 47. China Cerebrovascular Disease Market Size by Type (2015-2020) (Million US$)
Table 48. China Cerebrovascular Disease Market Share by Type (2015-2020)
Table 49. China Cerebrovascular Disease Market Size by Application (2015-2020) (Million US$)
Table 50. China Cerebrovascular Disease Market Share by Application (2015-2020)
Table 51. Japan Key Players Cerebrovascular Disease Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Cerebrovascular Disease Market Share (2019-2020)
Table 53. Japan Cerebrovascular Disease Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Cerebrovascular Disease Market Share by Type (2015-2020)
Table 55. Japan Cerebrovascular Disease Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Cerebrovascular Disease Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Cerebrovascular Disease Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Cerebrovascular Disease Market Share (2019-2020)
Table 59. Southeast Asia Cerebrovascular Disease Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Cerebrovascular Disease Market Share by Type (2015-2020)
Table 61. Southeast Asia Cerebrovascular Disease Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Cerebrovascular Disease Market Share by Application (2015-2020)
Table 63. India Key Players Cerebrovascular Disease Revenue (2019-2020) (Million US$)
Table 64. India Key Players Cerebrovascular Disease Market Share (2019-2020)
Table 65. India Cerebrovascular Disease Market Size by Type (2015-2020) (Million US$)
Table 66. India Cerebrovascular Disease Market Share by Type (2015-2020)
Table 67. India Cerebrovascular Disease Market Size by Application (2015-2020) (Million US$)
Table 68. India Cerebrovascular Disease Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Cerebrovascular Disease Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Cerebrovascular Disease Market Share (2019-2020)
Table 71. Central & South America Cerebrovascular Disease Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Cerebrovascular Disease Market Share by Type (2015-2020)
Table 73. Central & South America Cerebrovascular Disease Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Cerebrovascular Disease Market Share by Application (2015-2020)
Table 75. Johnson & Johnson Company Details
Table 76. Johnson & Johnson Business Overview
Table 77. Johnson & Johnson Product
Table 78. Johnson & Johnson Revenue in Cerebrovascular Disease Business (2015-2020) (Million US$)
Table 79. Johnson & Johnson Recent Development
Table 80. Amgen Company Details
Table 81. Amgen Business Overview
Table 82. Amgen Product
Table 83. Amgen Revenue in Cerebrovascular Disease Business (2015-2020) (Million US$)
Table 84. Amgen Recent Development
Table 85. GlaxoSmithKline Company Details
Table 86. GlaxoSmithKline Business Overview
Table 87. GlaxoSmithKline Product
Table 88. GlaxoSmithKline Revenue in Cerebrovascular Disease Business (2015-2020) (Million US$)
Table 89. GlaxoSmithKline Recent Development
Table 90. Sanofi-Aventis Company Details
Table 91. Sanofi-Aventis Business Overview
Table 92. Sanofi-Aventis Product
Table 93. Sanofi-Aventis Revenue in Cerebrovascular Disease Business (2015-2020) (Million US$)
Table 94. Sanofi-Aventis Recent Development
Table 95. Merck Company Details
Table 96. Merck Business Overview
Table 97. Merck Product
Table 98. Merck Revenue in Cerebrovascular Disease Business (2015-2020) (Million US$)
Table 99. Merck Recent Development
Table 100. Sangamo BioSciences Company Details
Table 101. Sangamo BioSciences Business Overview
Table 102. Sangamo BioSciences Product
Table 103. Sangamo BioSciences Revenue in Cerebrovascular Disease Business (2015-2020) (Million US$)
Table 104. Sangamo BioSciences Recent Development
Table 105. Aldagen Company Details
Table 106. Aldagen Business Overview
Table 107. Aldagen Product
Table 108. Aldagen Revenue in Cerebrovascular Disease Business (2015-2020) (Million US$)
Table 109. Aldagen Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cerebrovascular Disease Market Share by Type: 2020 VS 2026
Figure 2. Carotid Endarterectomy Features
Figure 3. Carotid Angioplasty Or Carotid Artery Stenting Features
Figure 4. Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone) Features
Figure 5. Global Cerebrovascular Disease Market Share by Application: 2020 VS 2026
Figure 6. Academic & Research Institutes Case Studies
Figure 7. Pharmaceutical & Biotechnology Companies Case Studies
Figure 8. Hospitals & Diagnostic Centers Case Studies
Figure 9. Contract Research Organizations Case Studies
Figure 10. Others Case Studies
Figure 11. Cerebrovascular Disease Report Years Considered
Figure 12. Global Cerebrovascular Disease Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Cerebrovascular Disease Market Share by Regions: 2020 VS 2026
Figure 14. Global Cerebrovascular Disease Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Cerebrovascular Disease Market Share by Players in 2019
Figure 17. Global Top Cerebrovascular Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cerebrovascular Disease as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Cerebrovascular Disease Revenue in 2019
Figure 19. North America Cerebrovascular Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Cerebrovascular Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Cerebrovascular Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Cerebrovascular Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Cerebrovascular Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Cerebrovascular Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Cerebrovascular Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
冠動脈疾患治療薬の世界市場（～2026年） Coronary artery disease (CAD), also known as ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death. Our research analysis on the global coronary artery disease therapeutics market has identified that…- 重症筋無力症の世界市場（～2026年） Myasthenia gravis (MG) is a long-term neuromuscular disease that leads to varying degrees of skeletal muscle weakness. The most commonly affected muscles are those of the eyes, face, and swallowing. It can result in double vision, drooping eyelids, trouble talking, and trouble walking. Onset can be …
- クローン病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Crohn’s Disease Drug Market The global Crohn’s Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Crohn’s Disease Drug Scope and Market Size Crohn’s Disease Drug market is…
- クッシング病治療の世界市場（～2026年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
- クラッベ病治療の世界市場（～2026年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…